Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'Foster, NL' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 66 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Doody, RS; Dunn, JK; Clark, CM; Farlow, M; Foster, NL; Liao, T; Gonzales, N; Lai, E; Massman, P
      Chronic donepezil treatment is associated with slowed cognitive decline inAlzheimer's disease

      DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    2. Connell, CM; Shaw, BA; Holmes, SB; Foster, NL
      Caregivers' attitudes toward their family members' participation in Alzheimer disease research: Implications for recruitment and retention

      ALZHEIMER DISEASE & ASSOCIATED DISORDERS
    3. Barbas, NR; Foster, NL
      Social and ethical issues in the care of patients with dementia

      JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY
    4. Zubieta, JK; Koeppe, AR; Frey, KA; Kilbourn, MR; Mangner, TJ; Foster, NL; Kuhl, DE
      Assessment of muscarinic receptor concentrations in affinity and Alzheimerdisease with [C-11]NMPB and PET

      SYNAPSE
    5. Minoshima, S; Foster, NL; Sima, AAF; Frey, KA; Albin, RL; Kuhl, DE
      Alzheimer's disease versus dementia with Lewy bodies: Cerebral metabolic distinction with autopsy confirmation

      ANNALS OF NEUROLOGY
    6. Kuhl, DE; Minoshima, S; Frey, KA; Foster, NL; Kilbourn, MR; Koeppe, RA
      Central acetylcholinesterase inhibition in Alzheimer patients - Reply

      ANNALS OF NEUROLOGY
    7. Lynch, T; Sano, M; Marder, KS; Bell, KL; Foster, NL; Defendini, RF; Sima, AAF; Keohane, C; Nygaard, TG; Fahn, S; Mayeux, R; Rowland, LP; Wilhelmsen, KC
      Clinical characteristics of a family with chromosome 17-linked disinhibition-dementia-parkinsonism-amyotrophy complex

      NEUROLOGY
    8. Kluin, KJ; Gilman, S; Foster, NL; D'Amato, CJ; Bluemlein, L; Little, R; Sima, AAF; Bruch, LA; Johanns, JR
      Neuropathologic correlates of dysarthria in progressive supranuclear palsy- In reply

      ARCHIVES OF NEUROLOGY
    9. Bozoki, A; Giordani, B; Heidebrink, JL; Berent, S; Foster, NL
      Mild cognitive impairments predict dementia in nondemented elderly patients with memory loss

      ARCHIVES OF NEUROLOGY
    10. Kluin, KJ; Gilman, S; Foster, NL; Sima, AAF; D'Amato, CJ; Bruch, LA; Bluemlein, L; Little, R; Johanns, J
      Neuropathological correlates of dysarthria in progressive supranuclear palsy

      ARCHIVES OF NEUROLOGY
    11. Kuhl, DE; Minoshima, S; Frey, KA; Foster, NL; Kilbourn, MR; Koeppe, RA
      Limited donepezil inhibition of acetylcholinesterase measured with positron emission tomography in living Alzheimer cerebral cortex

      ANNALS OF NEUROLOGY
    12. Foster, NL; Gombosi, E; Teboe, C; Little, RJA
      Balanced centralized and distributed database design in a clinical research environment

      STATISTICS IN MEDICINE
    13. Teri, L; Logsdon, RG; Peskind, E; Raskind, M; Weiner, MF; Tractenberg, RE; Foster, NL; Schneider, LS; Sano, M; Whitehouse, P; Tariot, P; Mellow, AM; Auchus, AP; Grundman, M; Thomas, RG; Schafer, K; Thal, LJ
      Treatment of agitation in AD - A randomized, placebo-controlled clinical trial

      NEUROLOGY
    14. Foster, NL; Minoshima, S; Johanns, J; Little, R; Heumann, ML; Kuhl, DE; Gilman, S
      PET measures of benzodiazepine receptors in progressive supranuclear palsy

      NEUROLOGY
    15. Sima, AAF; D'Amato, C; Foster, NL
      Neuropathology of chromosome-17-linked dementia

      DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    16. Kuhl, DE; Koeppe, RA; Minoshima, S; Snyder, SE; Ficaro, EP; Foster, NL; Frey, KA; Kilbourn, MR
      In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer's disease

      NEUROLOGY
    17. Foster, NL; Hickenbottom, SL
      When do strokes cause dementia? Effects of subcortical cerebral infarctionon cortical glucose metabolism and cognitive function

      ARCHIVES OF NEUROLOGY
    18. FONTANA RJ; DEVRIES TM; WOOLF TF; KNAPP MJ; BROWN AS; KAMINSKY LS; TANG BK; FOSTER NL; BROWN RR; WATKINS PB
      CAFFEINE BASED MEASURES OF CYP1A2 ACTIVITY CORRELATE WITH ORAL CLEARANCE OF TACRINE IN PATIENTS WITH ALZHEIMERS-DISEASE

      British journal of clinical pharmacology
    19. FOSTER NL
      THE DEVELOPMENT OF BIOLOGICAL MARKERS FOR THE DIAGNOSIS OF ALZHEIMERS-DISEASE

      Neurobiology of aging
    20. MINOSHIMA S; GIORDANI B; BERENT S; FREY KA; FOSTER NL; KUHL DE
      [F-18] FDG PET PREDICTS THE DEVELOPMENT OF ALZHEIMERS-DISEASE IN MEMORY-IMPAIRED PATIENTS WITHOUT DEMENTIA

      The Journal of nuclear medicine
    21. NISHIMURA S; MINOSHIMA S; GIORDANI B; JOHANNS J; LITTLE RJA; FOSTER NL; KUHL DE
      PREDICTING COGNITIVE DECLINE IN ALZHEIMERS-DISEASE USING POSITRON-EMISSION-TOMOGRAPHY

      The Journal of nuclear medicine
    22. BARTOK JA; WILSON CS; GIORDANI B; KEYS BA; PERSAD CC; FOSTER NL; BERENT S
      VARYING PATTERNS OF VERBAL RECALL, RECOGNITION, AND RESPONSE BIAS WITH PROGRESSION OF ALZHEIMERS-DISEASE

      Neuropsychology, development, and cognition. Section B, Aging, neuropsychology and cognition
    23. FISHER NJ; ROURKE BP; BIELIAUSKAS LA; GIORDANI B; BERENT S; FOSTER NL
      UNMASKING THE HETEROGENEITY OF ALZHEIMERS-DISEASE - CASE-STUDIES OF INDIVIDUALS FROM DISTINCT NEUROPSYCHOLOGICAL SUBGROUPS

      Neuropsychology, development, and cognition. Section A, Journal of clinical and experimental neuropsychology
    24. HEIDEBRINK JL; MINOSHIMA S; GIORDANI B; MELLOW AM; JOHANNS JR; LITTLE RJA; FOSTER NL
      BEHAVIORAL-EFFECTS OF KETAMINE CANNOT BE EXPLAINED BY CINGULATE ACTIVATION

      Annals of neurology
    25. HEIDEBRINK JL; GIORDANI B; MELLOW AM; JOHANNS JR; LITTLE RJA; FOSTER NL
      PHENOBARBITAL DOES NOT REDUCE THE ADVERSE-EFFECTS OF LOW-DOSE KETAMINE

      Annals of neurology
    26. MINOSHIMA S; GIORDANI B; BERENT S; FREY KA; FOSTER NL; KUHL DE
      METABOLIC REDUCTION IN THE POSTERIOR CINGULATE CORTEX IN VERY EARLY ALZHEIMERS-DISEASE

      Annals of neurology
    27. FOSTER NL; WILHELMSEN K; SIMA AAF; JONES MZ; DAMATO CJ; GILMAN S; SPILLANTINI MG; LYNCH T; MAYEUX RP; GASKELL PC; HULETTE CM; PERICAKVANCE MA; WELSHBOHMER KA; DICKSON DW; HEUTINK P; KROS J; VANSWIETEN JC; ARWERT F; GHETTI MB; MURRELL J; LANNFELT L; HUTTON M; JONES M; PHELPS CH; SNYDER DS; OLIVER E; BALL MJ; CUMMINGS JL; MILLER BL; KATZMAN R; REED L; SCHELPER RL; LANDSKA DJ; BRUN A; FINK JK; KUHL DE; KNOPMAN DS; WSZOLEK Z; MILLER CA; BIRD TD; LENDON C; ELECHI C
      FRONTOTEMPORAL DEMENTIA AND PARKINSONISM LINKED TO CHROMOSOME-17 - A CONSENSUS CONFERENCE

      Annals of neurology
    28. MINOSHIMA S; FOSTER NL; FREY KA; WAHL RL; BURDETTE JH; KUHL DE
      CAN FDG PET DISTINGUISH DEMENTIA PATIENTS WITH CORTICAL LEWY BODIES FROM PURE ALZHEIMERS-DISEASE

      The Journal of nuclear medicine
    29. VANDERBORGHT T; MINOSHIMA S; GIORDANI B; FOSTER NL; FREY KA; BERENT S; ALBIN RL; KOEPPE RA; KUHL DE
      CEREBRAL METABOLIC DIFFERENCES IN PARKINSONS AND ALZHEIMERS-DISEASES MATCHED FOR DEMENTIA SEVERITY

      The Journal of nuclear medicine
    30. MURMAN DL; GIORDANI B; MELLOW AM; JOHANNS JR; LITTLE RJA; HARIHARAN M; FOSTER NL
      COGNITIVE, BEHAVIORAL, AND MOTOR EFFECTS OF THE NMDA ANTAGONIST KETAMINE IN HUNTINGTONS-DISEASE

      Neurology
    31. KLUIN KJ; GILMAN S; FOSTER NL; SIMA AAF; DAMATO C; BRUCH LA; BLUEMLEIN L; LITTLE RJ; JOHANNS J
      DEGENERATION OF SUBSTANTIA-NIGRA PARS COMPACTA CONTRIBUTES TO THE DYSARTHRIA OF PSP

      Neurology
    32. HEIDEBRINK JL; MILLETT SL; JONES MZ; FOSTER NL
      DIFFERENCES BETWEEN ALZHEIMERS-DISEASE IN THE COMMUNITY AND AT AN ACADEMIC REFERRAL CENTER

      Journal of neuropathology and experimental neurology
    33. FISHER NJ; ROURKE BP; BIELIAUSKAS L; GIORDANI B; BERENT S; FOSTER NL
      NEUROPSYCHOLOGICAL SUBGROUPS OF PATIENTS WITH ALZHEIMERS-DISEASE

      Neuropsychology, development, and cognition. Section A, Journal of clinical and experimental neuropsychology
    34. MURMAN DL; FOSTER NL; KILGORE SP; MCDONAGH CA; FINK JK
      APOLIPOPROTEIN-E AND ALZHEIMERS-DISEASE - STRENGTH OF ASSOCIATION IS RELATED TO AGE AT ONSET

      Dementia
    35. FOSTER NL; PETERSEN RC; GRACON SI; LEWIS K
      AN ENRICHED-POPULATION, DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSSOVER STUDY OF TACRINE AND LECITHIN IN ALZHEIMERS-DISEASE

      Dementia
    36. HEIDEBRINK JL; GOMBOSI E; CORNELLIER DS; LEWITT PA; FOSTER NL
      DO SATELLITE DIAGNOSTIC AND TREATMENT CENTERS OVERCOME REFERRAL BIAS IN DEMENTIA RESEARCH

      Annals of neurology
    37. KUHL DE; MINOSHIMA S; FESSLER JA; FREY KA; FOSTER NL; FICARO EP; WIELAND DM; KOEPPE RA
      IN-VIVO MAPPING OF CHOLINERGIC TERMINALS IN NORMAL AGING, ALZHEIMERS-DISEASE, AND PARKINSONS-DISEASE

      Annals of neurology
    38. SIMA AAF; DEFENDINI R; KEOHANE C; DAMATO C; FOSTER NL; PARCHI P; GAMBETTI P; LYNCH T; WILHELMSEN KC
      THE NEUROPATHOLOGY OF CHROMOSOME 17-LINKED DEMENTIA

      Annals of neurology
    39. FONTANA RJ; TURGEON DK; WOOLF TF; KNAPP MJ; FOSTER NL; WATKINS PB
      THE CAFFEINE BREATH TEST DOES NOT IDENTIFY PATIENTS SUSCEPTIBLE TO TACRINE HEPATOTOXICITY

      Hepatology
    40. MINOSHIMA S; GIORDANI BL; BERENT S; FREY KA; FOSTER NL; KUHL DE
      THE POSTERIOR CINGULATE CORTEX - THE EARLIEST METABOLIC REDUCTION IN ALZHEIMERS-DISEASE AS REVEALED BY PET

      The Journal of nuclear medicine
    41. MINOSHIMA S; FREY KA; GIORDANI BL; FOSTER NL; KOEPPE RA; BERENT S; ALBIN RL; KUHL DE
      TECHNICAL FEASIBILITY AND INITIAL DIAGNOSTIC APPLICATION OF FUNCTIONAL BRAIN IMAGE DATABASE SYSTEM IN DEMENTIA

      The Journal of nuclear medicine
    42. FREY KA; MURMAN DL; MINOSHIMA S; FOSTER NL; BUCHTEL HA; KUHL DE
      DIAGNOSTIC EVALUATION OF [F-18] FDG PET SCANNING IN PATIENTS UNDERGOING EVALUATION FOR DEMENTIA

      The Journal of nuclear medicine
    43. COCHRAN EJ; BENNETT DA; CERVENAKOVA L; KENNEY K; BERNARD B; FOSTER NL; BENSON DF; GOLDFARB LG; BROWN P
      FAMILIAL CREUTZFELDT-JAKOB-DISEASE WITH A 5-REPEAT OCTAPEPTIDE INSERTMUTATION

      Neurology
    44. KNOPMAN D; SCHNEIDER L; DAVIS K; TALWALKER S; SMITH F; HOOVER T; GRACON S; APTER JT; BARNETT M; BAUMEL B; EISNER LS; BENNETT D; FORCHETTI C; BLASS JP; BORISON RL; CELESIA GG; DEXTER J; DOODY R; DUBOFF EA; EARL NL; FARLOW M; HENDRIE HC; FARMER M; FERGUSON J; FOSTER NL; GREENWALD M; GROENENDYK A; JURKOWSKI C; KATZ I; PRODNER CK; KNOPMAN DS; MARGOLIN RA; MORRIS JC; RUBIN EH; REYES PF; RYMER MM; SADOWSKY CH; PAWLUCZYK S; SMITH WT; SOLOMON PR; PENDLEBURY WW; TAYLOR J; THEIN SG; TUTTLE P; TYNDALL RJ
      LONG-TERM TACRINE (COGNEX) TREATMENT - EFFECTS ON NURSING-HOME PLACEMENT AND MORTALITY

      Neurology
    45. FOSTER NL; SIMA AAF; DAMATO C; BRUCH LA; KLUIN K; BLUEMLEIN LA; LITTLE RJ; JOHANNS J; GILMAN S
      CEREBRAL CORTICAL PATHOLOGY IN PROGRESSIVE SUPRANUCLEAR PALSY IS CORRELATED WITH SEVERITY OF DEMENTIA

      Neurology
    46. GILMAN S; FOSTER NL
      THE ALZHEIMERIZATION OF AGING - A RESPONSE

      The Gerontologist
    47. BUTTER CM; TROBE JD; FOSTER NL; BERENT S
      VISUAL-SPATIAL DEFICITS EXPLAIN VISUAL SYMPTOMS IN ALZHEIMERS-DISEASE

      American journal of ophthalmology
    48. MCDANIEL KD; EDLAND SD; HEYMAN A; HARRELL L; HENDERSON V; WIEDERHOLT WC; KARP H; EVANS DA; BENNETT DA; CLARK DB; BRANDT J; GROWDON J; FOSTER NL; MORTIMER J; MORRIS J; BLASS J; MAYEUX R; MOHS R; FERRIS S; TARIOT P; EARL NL; FRIEDLAND R; CLARK C; DEKOSKY ST; DOODY R; WEINER M; LARSON E; RASKIND M; BERG L; VANBELLE G; FILLENBAUM G
      RELATIONSHIP BETWEEN LEVEL OF INSIGHT AND SEVERITY OF DEMENTIA IN ALZHEIMER-DISEASE

      Alzheimer disease and associated disorders
    49. MINOSHIMA S; FREY KA; FOSTER NL; KUHL DE
      PRESERVED PONTINE GLUCOSE-METABOLISM IN ALZHEIMER-DISEASE - A REFERENCE REGION FOR FUNCTIONAL BRAIN IMAGE (PET) ANALYSIS

      Journal of computer assisted tomography
    50. MINOSHIMA S; FREY KA; KOEPPE RA; FOSTER NL; KUHL DE
      A DIAGNOSTIC-APPROACH IN ALZHEIMERS-DISEASE USING 3-DIMENSIONAL STEREOTAXIC SURFACE PROJECTIONS OF FLUORINE-18-FDG PET

      The Journal of nuclear medicine
    51. GROOM GN; JUNCK L; FOSTER NL; FREY KA; KUHL DE
      PET OF PERIPHERAL BENZODIAZEPINE BINDING-SITES IN THE MICROGLIOSIS OFALZHEIMERS-DISEASE

      The Journal of nuclear medicine
    52. ALEXANDER NB; MOLLO JM; GIORDANI B; ASHTONMILLER JA; SCHULTZ AB; GRUNAWALT JA; FOSTER NL
      MAINTENANCE OF BALANCE, GAIT PATTERNS, AND OBSTACLE CLEARANCE IN ALZHEIMERS-DISEASE

      Neurology
    53. MURMAN DL; GIORDANI B; MELLOW AM; JOHANNS JR; LITTLE RJA; FOSTER NL
      COGNITIVE, BEHAVIORAL, AND MOTOR EFFECTS OF THE NMDA ANTAGONIST KETAMINE IN HUNTINGTONS-DISEASE

      Neurology
    54. SIMA AAF; DAMATO C; FOSTER NL; LYNCH T; DEFENDINI RF; WILHELMSEN KC
      NEURONAL AND GLIAL INCLUSIONS IN FAMILIAL PROGRESSIVE LIMBIC LOBE SCLEROSIS

      Journal of neuropathology and experimental neurology
    55. MEYER M; KOEPPE RA; FREY KA; FOSTER NL; KUHL DE
      POSITRON EMISSION TOMOGRAPHY MEASURES OF BENZODIAZEPINE BINDING IN ALZHEIMERS-DISEASE

      Archives of neurology
    56. MURMAN DL; FREY KA; KNESPER DJ; GIORDANI B; BERENT S; KUHL DE; FOSTER NL
      CLINICAL AND NEUROPSYCHOMETRIC PREDICTORS OF PROGRESSION IN PATIENTS WITH COMPLAINTS OF MEMORY LOSS

      Annals of neurology
    57. ZUBIETA JK; FREY KA; KOEPPE RA; KILBOURN MR; MULHOLLAND GK; FOSTER NL; KUHL DE
      MUSCARINIC RECEPTOR-BINDING IN AGING AND ALZHEIMERS-DISEASE DETERMINED WITH [C-11] N-METHYL-4-PIPERIDYL BENZILATE AND PET

      The Journal of nuclear medicine
    58. MINOSHIMA S; FOSTER NL; KUHL DE
      POSTERIOR CINGULATE CORTEX IN ALZHEIMERS-DISEASE

      Lancet
    59. KNAPP MJ; KNOPMAN DS; SOLOMON PR; PENDLEBURY WW; DAVIS CS; GRACON SI; APTER JT; LAZARUS CN; BAKER KE; BARNETT M; BAUMEL B; EISNER LS; CASTELLS B; BOLOURI R; BENNETT D; FORCHETTI C; LEVIN A; BLASS JP; NOLAN KA; GAINES ER; RELKIN N; BORISON RL; DIAMOND B; CELESIA GG; ROSS AP; DEXTER J; DOODY R; LIPSCOMB L; KREITER K; DUBOFF EA; BLOCK P; MARSHALL D; WESTERGAARD N; EARL NL; WYNE SV; HINMANSMITH E; FARLOW M; HENDRIE HC; CARESS JA; FARMER M; HARPER JE; FERGUSON J; FOSTER NL; BARBAS NR; BLUEMLEIN LA; GELB DJ; BERENT S; GIORDANI B; GREENWALD M; BERGMAN S; ROGER LF; GROENENDYK A; WOOD M; JURKOWSKI C; KATZ I; DOYLE S; SMITH BD; KELLNER C; BERNSTEIN HJ; BACHMAN DL; KNOPMAN DS; DEINARD S; LANGLEY L; BRIDGES S; MARGOLIN RA; BURGER MC; WISER SL; CRENSHAW C; MORRIS JC; RUBIN EH; COATS MA; REYES PF; BENTZ C; DOYLE LL; RYMER MM; BETTINGER IE; LAUBINGER MP; SADOWSKY CH; MARTINEZ W; ZUNIGA J; STONE R; WINNER P; MATE L; LESSARD C; SCHNEIDER L; PAWLUCZYK S; SMITH WT; LOSK SN; MARAMBE L; SOLOMON PR; PENDLEBURY WW; GROCCIAELLISON ME; EDWARDS KR; TAYLOR J; CALABRESE VP; HARKINS SW; THEIN SG; DEWAR JA; WILLIAMS G; DRENNAN C; TUTTLE P; PRINCIPI N; FORD EM; TYNDALL RJ; KELLEY CK
      A 30-WEEK RANDOMIZED CONTROLLED TRIAL OF HIGH-DOSE TACRINE IN PATIENTS WITH ALZHEIMERS-DISEASE

      JAMA, the journal of the American Medical Association
    60. LYNCH T; SANO M; MARDER KS; BELL KL; FOSTER NL; DEFENDINI RF; SIMA AAF; KEOHANE C; NYGAARD TG; FAHN S; MAYEUX R; ROWLAND LP; WILHELMSEN KC
      CLINICAL CHARACTERISTICS OF A FAMILY WITH CHROMOSOME 17-LINKED DISINHIBITION-DEMENTIA-PARKINSONISM-AMYOTROPHY COMPLEX

      Neurology
    61. GROOM GN; KOEPPE RA; FOSTER NL; STLAURENT RT; GIORDANI BJ; KUHL DE
      THE EFFECT OF AGE OF ONSET ON REGIONAL CEREBRAL GLUCOSE-METABOLISM INALZHEIMERS-DISEASE

      The Journal of nuclear medicine
    62. HARA M; MINOSHIMA S; FOSTER NL; KUHL DE
      IS REGIONAL CEREBRAL BLOOD-FLOW COUPLED WITH GLUCOSE-METABOLISM IN ALZHEIMERS-DISEASE

      The Journal of nuclear medicine
    63. GROOM GN; JUNCK L; FOSTER NL; FREY KA; KUHL DE
      POSITRON EMISSION TOMOGRAPHY OF [C-11] PK 11195 BINDING TO PERIPHERALBENZODIAZEPINE RECEPTORS IN ALZHEIMERS-DISEASE

      The Journal of nuclear medicine
    64. SHOPE JT; HOLMES SB; SHARPE PA; GOODMAN C; IZENSON S; GILMAN S; FOSTER NL
      SERVICES FOR PERSONS WITH DEMENTIA AND THEIR FAMILIES - A SURVEY OF INFORMATION AND REFERRAL AGENCIES IN MICHIGAN

      The Gerontologist
    65. MELLOW AM; FOSTER NL; ARONSON SM; GIORDANI B; STLAURENT RT; BERENT S
      BEHAVIORAL-EFFECTS OF THE NMDA ANTAGONIST, KETAMINE, IN ALZHEIMERS-DISEASE

      Biological psychiatry
    66. MORGAN MC; MCCUNE WJ; FOSTER NL; BRUNBERG J; BERENT S; KUHL D
      CORRELATIONS BETWEEN POSITRON EMISSION TOMOGRAPHY (PET) AND MAGNETIC-RESONANCE-IMAGING (MRI) IN LUPUS PATIENTS WITH AND WITHOUT DEMENTIA

      Arthritis and rheumatism


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 03/08/20 alle ore 14:53:35